No abstract available
MeSH terms
-
Adolescent
-
Adolescent Health Services
-
Alphapapillomavirus*
-
Cost-Benefit Analysis
-
Developing Countries*
-
Drug Costs
-
Female
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Humans
-
Papillomavirus Infections / prevention & control*
-
Papillomavirus Vaccines* / economics
-
Uterine Cervical Neoplasms / epidemiology
-
Uterine Cervical Neoplasms / prevention & control*
Substances
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Papillomavirus Vaccines
-
human papillomavirus vaccine, L1 type 16, 18